Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification
Mycoses · 2023
DOI: 10.1111/myc.13633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2023. Verfasst von Constanza Giselle Taverna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento Micología, Instituto Nacional de Enfermedades Infecciosas "Dr. Carlos G. Malbrán", Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Candida, Yeasts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Rapid and accurate yeasts species identification in clinical laboratories is important for appropriate and timely antifungal treatment. We evaluate the performance of the new medium CHROMagar™ Candida Plus for presumptive identification of yeasts species and MALDI‐TOF identification. We identify 303 strains belonging to 60 clinically relevant yeasts species by using the new medium. Presumptive identification was correct at the Candida albicans complex, Candida tropicalis and Pichia kudriavzevii ( Candida krusei ) species. However, although this medium was able to identify all Candida auris and Candida glabrata strains, other species were misidentified as C. auris or C. glabrata . A total of 215 strains were identified by using MALDI‐TOF and evaluated two incubation temperatures (30°C and 37°C) and two incubation times (24 h and 72 h). Most strains (94%; 202/215) were correctly identified at the species (n:190) or complex level (n:12) at both temperatures and incubation times. However, we observed that the time of incubation (24 h vs. 72 h) affects the score values when yeasts are incubated at 37°C, but does not affect score values when yeasts are incubated at 30°C. In conclusion, the new medium has a good performance in the presumptive identification of the C. albicans complex, C. tropicalis and P. kudriavzevii ( C. krusei ). In addition, this medium is useful for the screening of C. auris and C. glabrata isolates, but identification should be confirmed by other more specific techniques, like MALDI‐TOF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento Micología, Instituto Nacional de Enfermedades Infecciosas "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
- Departamento de Parasitología, Instituto Nacional de Enfermedades Infecciosas "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
ORCID-Profile: Constanza Giselle Taverna
Zitieren
APA
Taverna, C. G., Vivot, M. E., Arias, B. A., Irazu, L., & Canteros, C. E. (2023). Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification. Mycoses. https://doi.org/10.1111/myc.13633
Vancouver
Taverna CG, Vivot ME, Arias BA, Irazu L, Canteros CE. Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification. Mycoses. 2023. doi:10.1111/myc.13633
BibTeX
@article{Taverna2023,
author = {Taverna, Constanza Giselle and Vivot, Matías Ezequiel and Arias, Bárbara Abigail and Irazu, Lucia and Canteros, Cristina Elena},
title = {Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification},
journal = {Mycoses},
year = {2023},
doi = {10.1111/myc.13633}
}
EUVIMED